 VALENCIA, Calif. and MELBOURNE, Australia, Jan. 28, 2021 GLOBE NEWSWIRE -- AVITA Medical, Inc. NASDAQ: RCEL, ASX: AVH, a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs, announced today it plans to release its fiscal second quarter 2021 financial results after the market closes on Thursday, February 11, 2021. In conjunction with such release, the Company plans to host a conference call and webcast on February 11th at 1:30 p.m. Pacific Time 4:30 p.m. Eastern Time to discuss its financial results and recent highlights. 